Xeris Biopharma Holdings (XERS) Times Interest Earned: 2020-2025
Historic Times Interest Earned for Xeris Biopharma Holdings (XERS) over the last 5 years, with Sep 2025 value amounting to $0.92.
- Xeris Biopharma Holdings' Times Interest Earned rose 155.78% to $0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.33, marking a year-over-year increase of 121.80%. This contributed to the annual value of -$1.10 for FY2024, which is 33.30% up from last year.
- Per Xeris Biopharma Holdings' latest filing, its Times Interest Earned stood at $0.92 for Q3 2025, which was up 52.24% from $0.61 recorded in Q2 2025.
- In the past 5 years, Xeris Biopharma Holdings' Times Interest Earned ranged from a high of $0.92 in Q3 2025 and a low of -$26.82 during Q4 2021.
- For the 3-year period, Xeris Biopharma Holdings' Times Interest Earned averaged around -$0.92, with its median value being -$1.02 (2024).
- In the last 5 years, Xeris Biopharma Holdings' Times Interest Earned slumped by 537.75% in 2021 and then spiked by 159.18% in 2025.
- Over the past 5 years, Xeris Biopharma Holdings' Times Interest Earned (Quarterly) stood at -$26.82 in 2021, then soared by 87.05% to -$3.47 in 2022, then spiked by 59.58% to -$1.40 in 2023, then spiked by 115.53% to $0.22 in 2024, then skyrocketed by 155.78% to $0.92 in 2025.
- Its Times Interest Earned stands at $0.92 for Q3 2025, versus $0.61 for Q2 2025 and -$0.42 for Q1 2025.